Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.

Published in:

Investigational New Drugs, 2013, v. 31, n. 1, p. 30, doi. 10.1007/s10637-012-9828-4

By:

• Ma, Brigette B. Y.;
• Lui, Vivian W. Y.;
• Cheung, Crystal S.;
• Lau, Cecilia P. Y.;
• Ho, Kakiu;
• Hui, Edwin P.;
• Tsui, Stephen K. W.;
• Ng, Margaret H.;
• Cheng, S. H.;
• Ng, Patrick K. S.;
• Tsao, Sai Wai;
• Chan, Anthony T. C.

Publication type:

Article